Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest pharmaceutical industry Stories

2014-04-22 12:30:16

KING OF PRUSSIA, Pa., April 22, 2014 /PRNewswire/ -- Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced the release of new visual analytics functionality for its eClinicalGPS technology. The new functionality is designed to empower Greenphire's clients to transform the clinical payment management process into a method of aggregating strategic data that enables more effective clinical trial forecasting, planning, tracking and...

2014-04-22 08:33:07

Company Achieves Second Regulatory Clearance for Oxidation-Reduction Potential Platform GREENWOOD VILLAGE, Colo., April 22, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc., (NYSE MKT: AMPE) today announced that its subsidiary Luoxis, an in vitro diagnostics company, has obtained Health Canada Class II Medical Device approval for its RedoxSYS(TM) Diagnostic System, the company's blood-based platform for assessing the level of oxidative stress in the body....

2014-04-22 08:33:05

BUENA, N.J., April 22, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Tuesday, April 29, 2014 to discuss the 1st quarter 2014 results. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO The Company invites you to listen to the call by dialing 1-866-515-2913. International participants should call 1-617-399-5127. The...

2014-04-22 08:32:58

- Potential Therapeutic Candidates Now Identified for All Three GSK Collaboration Targets - CAMBRIDGE, Mass., April 22, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced the achievement of the lead candidate milestone for the third of the three histone methyltransferase (HMT) targets in the company's collaboration with GSK and is...

2014-04-22 00:21:28

- $5.4 billion deal creates world's second-largest animal health company. INDIANAPOLIS, April 22, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in an all-cash transaction that will strengthen and diversify Lilly's own animal health business, Elanco. Upon completion of the acquisition, Elanco will be the second-largest animal health company in terms of global revenue, will...

2014-04-21 23:10:20

Verified Clinical Trials is proud to announce their presence at the 2014 Annual DIA meeting in San Diego, California. Verified Clinical Trials will discuss the largest North American clinical research volunteer database that stops dual enrollment in clinical trials, while promoting patient safety and data quality. Garden City, New York (PRWEB) April 21, 2014 Verified Clinical Trials (VCT) will again be an exhibitor at the the 2014 Annual DIA Meeting in San Diego. While at the conference,...

2014-04-21 23:07:05

Live webinar to focus on implementing an automated SUSAR System to investigators in clinical trials. The broadcast takes place on Thursday, May 8, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 21, 2014 Investigators, health authorities, and ethics committees need to be informed in a timely manner of new and updated SUSARs and SAEs, since these safety reports are an essential requirement for sponsors of clinical trials. Using an automated and secure electronic...

2014-04-21 12:27:49

SOUTH PLAINFIELD, N.J., April 21, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 17, 2014 it granted non-statutory stock options to purchase an aggregate of 9,800 shares of its common stock to four new employees. The grant was made pursuant to the NASDAQ inducement grant exception as a component of our new hires' employment compensation. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The inducement grants were approved by PTC's...

2014-04-21 12:26:38

MUMBAI, India and BALTIMORE, April 21, 2014 /PRNewswire/ -- Pharma major Lupin today announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations. Theresa will assume full responsibility for global merger and acquisitions and specialty business strategy. Prior to joining Lupin, Theresa was with Aptalis pharma as the Chief Corporate Development Officer responsible for Mergers & Acquisitions (M&A), Strategy and Global...

2014-04-21 12:25:01

Drug Prices are to Remain High in Vietnam, Due to Limited Domestic Drug Production and a Lack of Cost-Containment Measures, According to Findings from Decision Resources Group BURLINGTON, Mass., April 21, 2014 /PRNewswire/ -- Decision Resources Group finds that Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a growth rate of nearly 17 percent and exceeding $3 billion in size in 2013. Increasing affluence, a rapidly aging population and the...